Introduction

Indian Pharmacopoeia Commission (IPC) is an autonomous institution of the Ministry of Health and Family Welfare which sets standards for all drugs that are manufactured, sold and consumed in India.

Outline

The set of standards are published under the title Indian Pharmacopoeia (IP) which has been modelled on and historically follows from the British Pharmacopoeia. The standards that are in effect since 01 December 2010, are the Indian Pharmacopoeia 2010 (IP 2010). The Pharmacopoeia 2014 was released by Health Minister Ghulam Nabi Azad on 04 November 2013. The Pharmacopoeia 2018 was released by Secretary, Ministry of Health & Family Welfare, Government of India.

IP, the abbreviation of ‘Indian Pharmacopoeia’ is familiar to the consumers in the Indian sub-continent as a mandatory drug name suffix. Drugs manufactured in India have to be labelled with the mandatory non-proprietary drug name with the suffix IP. This is similar to the BP suffix for British Pharmacopoeia and the USP suffix for the United States Pharmacopeia.

The IPC was formed according to the Indian Drugs and Cosmetics Act of 1940 and established by executive orders of the Government of India in 1956.

History of Publication

The actual process of publishing the first Pharmacopoeia started in the year 1944 under the chairmanship of Colonel R.N. Chopra. The IP list was first published in the year 1946 and was put forth for approval. The titles are suffixed with the respective years of publication, e.g. IP 1996. The following table describes the publication history of the Indian Pharmacopoeia.

• 1st Edition 1955:
  • Supplement 1960
• 2nd Edition 1966:
  • Supplement 1975
• 3rd Edition 1985:
  • 2 volumes.
  • Addendum 1989.
  • Addendum 1991.
• 4th Edition 1996:
  • 2 volumes.
  • Addendum 2000.
  • Vet Supplement 2000.
  • Addendum 2002.
  • Addendum 2005.
• 5th Edition 2007:
  • 3 volumes.
  • Addendum 2008.
• 6th Edition 2010:
  • 3 volumes.
  • Addendum 2012.
• 7th Edition 2014:
  • 4 volumes.
  • Addendum 2015.
  • Addendum 2016.
• 8th Edition 2018:
  • 4 volumes.
  • Addendum 2019.
  • Addendum 2021.

Refer to The International Pharmacopoeia, British Pharmacopoeia, European Pharmacopoeia, United States Pharmacopoeia, Indian Pharmacopoeia Commission, Japanese Pharmacopoeia, and Pharmacopoeia of the People’s Republic of China.

This page is based on the copyrighted Wikipedia article < https://en.wikipedia.org/wiki/Indian_Pharmacopoeia_Commission >; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA.